Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

China SXT Pharmaceuticals (SXTC) Equity Ratio: 2019-2025

Historic Equity Ratio for China SXT Pharmaceuticals (SXTC) over the last 7 years, with Mar 2025 value amounting to 0.71.

  • China SXT Pharmaceuticals' Equity Ratio rose 58.29% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year increase of 58.29%. This contributed to the annual value of 0.71 for FY2025, which is 18.32% up from last year.
  • As of FY2025, China SXT Pharmaceuticals' Equity Ratio stood at 0.71, which was up 18.32% from 0.60 recorded in FY2024.
  • Over the past 5 years, China SXT Pharmaceuticals' Equity Ratio peaked at 0.71 during FY2025, and registered a low of 0.46 during FY2021.
  • For the 3-year period, China SXT Pharmaceuticals' Equity Ratio averaged around 0.60, with its median value being 0.60 (2024).
  • Data for China SXT Pharmaceuticals' Equity Ratio shows a peak YoY grew of 21.17% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows China SXT Pharmaceuticals' Equity Ratio stood at 0.46 in 2021, then rose by 5.97% to 0.49 in 2022, then grew by 1.53% to 0.50 in 2023, then grew by 21.17% to 0.60 in 2024, then increased by 18.32% to 0.71 in 2025.